Dissociation and Protection of the Neurovascular Unit after Thrombolysis and Reperfusion in Ischemic Rat Brain

In the ischemic brain, reperfusion with tissue plasminogen activator (tPA) sometimes causes catastrophic hemorrhagic transformation (HT); however, the mechanism remains elusive. Here, we show that the basement membrane, and not the endothelial cells, is vulnerable to ischemic/reperfusion injury with tPA treatment. We treated a spontaneously hypertensive rat model of middle cerebral artery occlusion (MCAO) with vehicle alone, tPA alone, or a free radical scavenger, edaravone, plus tPA. Light and electron microscopic analyses of each microvascular component revealed that the basement membrane disintegrated and became detached from the astrocyte endfeet in tPA-treated animals that showed HT. On the other hand, edaravone prevented the dissociation of the neurovascular unit, dramatically decreased the HT, and improved the neurologic score and survival rate of the tPA-treated rats. These results suggest that the basement membrane that underlies the endothelial cells is a key structure for maintaining the integrity of the neurovascular unit, and a free-radical scavenger can be a viable agent for inhibiting tPA-induced HT.

[1]  C. Starmer,et al.  Na channel kinetics remain stable during perforated-patch recordings. , 1992, The American journal of physiology.

[2]  G. Hamann,et al.  Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  U. Modlich,et al.  Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. , 1995, The American journal of pathology.

[4]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  V. Cachofeiro,et al.  Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-κB/IκB system , 2005 .

[6]  J. Aschner,et al.  Bradykinin‐ and thrombin‐induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation , 1997, Journal of cellular physiology.

[7]  J. Koziol,et al.  Rapid Disruption of an Astrocyte Interaction With the Extracellular Matrix Mediated by Integrin α6β4 During Focal Cerebral Ischemia/Reperfusion , 1997 .

[8]  R. Keep,et al.  Iron and Iron-Handling Proteins in the Brain After Intracerebral Hemorrhage , 2003, Stroke.

[9]  J. Povlishock,et al.  Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. , 1992, The American journal of physiology.

[10]  Takeshi Hayashi,et al.  Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain , 2004, Neurological research.

[11]  G. Zoppo Stroke and Neurovascular Protection , 2006 .

[12]  Ulrich Dirnagl,et al.  Increased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[14]  J. Grotta,et al.  NXY-059 for acute ischemic stroke. , 2006, The New England journal of medicine.

[15]  J. Koziol,et al.  Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion. , 1997, Stroke.

[16]  P. Narasimhan,et al.  Evaluating therapeutic targets for reperfusion‐related brain hemorrhage , 2006, Annals of neurology.

[17]  L. Noble,et al.  Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier , 1998, Brain Research.

[18]  D. Lange,et al.  Ischemia/reperfusion-induced changes in membrane fluidity characteristics of brain capillary endothelial cells and its prevention by liposomal-incorporated superoxide dismutase. , 1991, Biochimica et biophysica acta.

[19]  P. Chan Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  T. N. t-P. S. S. Group,et al.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.

[21]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[22]  N. Omori,et al.  Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion , 2002, Brain Research.

[23]  G. D. del Zoppo,et al.  Cerebral Microvessel Responses to Focal Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  T. Watanabe,et al.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. , 1994, The Journal of pharmacology and experimental therapeutics.

[25]  G. Rosenberg Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[26]  K. Ballmer-Hofer,et al.  VEGF transiently disrupts gap junctional communication in endothelial cells. , 2001, Journal of cell science.

[27]  C. Korninger,et al.  Studies on the Specific Fibrinolytic Effect of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood and in Various Animal Species in Vitro , 1981, Thrombosis and Haemostasis.

[28]  Y. Guillaume,et al.  Time course of vascular arginase expression and activity in spontaneously hypertensive rats. , 2007, Life sciences.

[29]  S. Kuroda,et al.  Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the Rat , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Hans-Christoph Diener,et al.  NXY-059 for the treatment of acute ischemic stroke. , 2007, The New England journal of medicine.

[31]  D. DeLong,et al.  Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction , 2003, Cerebrovascular Diseases.

[32]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[33]  J. Garcìa,et al.  DNA scission after focal brain ischemia. Temporal differences in two species. , 1997, Stroke.

[34]  P. Agre,et al.  Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain , 1997, The Journal of Neuroscience.

[35]  N. Parinandi,et al.  Redox Regulation of 4-Hydroxy-2-nonenal-mediated Endothelial Barrier Dysfunction by Focal Adhesion, Adherens, and Tight Junction Proteins* , 2006, Journal of Biological Chemistry.

[36]  V. Serebruany NXY-059 for acute ischemic stroke. , 2006, The New England journal of medicine.

[37]  E. Lo,et al.  Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  K. Abe,et al.  Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. , 1988, Stroke.

[39]  T. Tamiya,et al.  Edaravone Attenuates Brain Edema and Neurologic Deficits in a Rat Model of Acute Intracerebral Hemorrhage , 2008, Stroke.

[40]  Y. Katayama,et al.  The Role of Bradykinin in Mediating Ischemic Brain Edema in Rats , 1993, Stroke.

[41]  Y. Yamamoto,et al.  Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. , 1996, Redox report : communications in free radical research.

[42]  K. Rhodes,et al.  Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators , 2007, Neuroscience Letters.

[43]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.